A Next Generation Cancer Treatment - Killing Cancer Tumors From The Inside Out

Vivos Inc.
(OTCQB: RDGL)

Vivos Inc. (OTCQB: RDGL)Vivos Inc. (OTCQB: RDGL)Vivos Inc. (OTCQB: RDGL)
Home
Press Releases
RadioGel®
IsoPet®
PRnT™
IDE Submission
Subscribe
The History of Vivos Inc.
The Peltier Chiller
Quarterly Reports
SEC Filings
Research Papers
Meet The Team
FAQ's
Contact Us

Vivos Inc.
(OTCQB: RDGL)

Vivos Inc. (OTCQB: RDGL)Vivos Inc. (OTCQB: RDGL)Vivos Inc. (OTCQB: RDGL)
Home
Press Releases
RadioGel®
IsoPet®
PRnT™
IDE Submission
Subscribe
The History of Vivos Inc.
The Peltier Chiller
Quarterly Reports
SEC Filings
Research Papers
Meet The Team
FAQ's
Contact Us
More
  • Home
  • Press Releases
  • RadioGel®
  • IsoPet®
  • PRnT™
  • IDE Submission
  • Subscribe
  • The History of Vivos Inc.
  • The Peltier Chiller
  • Quarterly Reports
  • SEC Filings
  • Research Papers
  • Meet The Team
  • FAQ's
  • Contact Us

  • Home
  • Press Releases
  • RadioGel®
  • IsoPet®
  • PRnT™
  • IDE Submission
  • Subscribe
  • The History of Vivos Inc.
  • The Peltier Chiller
  • Quarterly Reports
  • SEC Filings
  • Research Papers
  • Meet The Team
  • FAQ's
  • Contact Us

Subscribe

Be the first to hear about the latest press releases and news on our proprietary Precision Radionuclide Therapy™ (PRnT™)

Vivos Inc.

Vivos Inc. (OTCQB: RDGL)

Copyright © 2025 Vivos Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept